Full Text
EE432 Number Needed to Treat and Associated Costs/Additional Responder of Dupilumab Versus Tralokinumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis

Abstract

Authors

J Tavi K Noonan A Kuznik R Hudson

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×